Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $0 M | -99.43% |
2023 | $0.04 M | -90.92% |
2022 | $0.45 M | -96.63% |
2021 | $13.43 M | 144.84% |
2020 | $5.48 M | 23.52% |
2019 | $4.44 M | -68.28% |
2018 | $14 M | 571.95% |
2017 | $2.08 M | -82.71% |
2016 | $12.05 M | 381.52% |
2015 | $2.5 M | 80.46% |
2014 | $1.38 M | 600.93% |
2013 | $0.19 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Novartis NVS | $30.53 M | $95.22 M | ๐จ๐ญ Switzerland |
Eli Lilly LLY | $50.92 M | $0.12 B | ๐บ๐ธ USA |
Sanofi SNY | $26.25 M | $54.4 M | ๐ซ๐ท France |
Titan Pharmaceuticals
TTNP | $0.02 M | $0.13 M | ๐บ๐ธ USA |
Alkermes ALKS | $1.53 M | $34.07 M | ๐ฎ๐ช Ireland |
Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | ๐ฎ๐ฑ Israel |